(Q36984354)

English

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

scientific article published on 15 October 2007

Statements

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit